Publications by authors named "Sarah Rybowski"

Claim this Profile
R
Real-world outcomes in patients with brain metastases secondary to HR+/HER2- MBC treated with abemaciclib and local intracranial therapy.
Wambui Gathirua-Mwangi, Holly Martin, Dan He, Shen Zheng, Kristin M Sheffield, Sarah Rybowski

Oncologist· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Analysis of Clinical and Demographic Characteristics, Treatment Patterns, and Outcomes in Predominantly Older Patients with HR+/HER2- Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice.
Alistair Ring, Meghan Karuturi, Emily Nash Smyth, Tasneem Lokhandwala, Kristin M Sheffield, Sarah Rybowski

Drugs Real World Outcomes· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice.
Alistair Ring, Meghan Karuturi, Emily Nash Smyth, Tasneem Lokhandwala, Kristin M Sheffield, Sarah Rybowski

Adv Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with Abemaciclib.
Emily Nash Smyth, Julie Beyrer, Kimberly R Saverno, Elizabeth Hadden, Hamed Abedtash, Sarah Rybowski

Drugs Real World Outcomes· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world incidence and management of adverse events in patients with HR+, HER2- metastatic breast cancer receiving CDK4 and 6 inhibitors in a United States community setting.
Gregory L Price, Lavanya Sudharshan, Paula Ryan, Jonathan Rajkumar, Kristin M Sheffield, Sarah Rybowski

Curr Med Res Opin· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Prognostic Factor Index Among Women With HR/HER2 Metastatic Breast Cancer in a Community Oncology Setting.
Gregory A Vidal, Gebra Cuyun Carter, Adrienne M Gilligan, Kim Saverno, Yajun Emily Zhu, Sarah Rybowski

Clin Breast Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2- metastatic breast cancer.
Gebra Cuyun Carter, Kristin M Sheffield, Anala Gossai, Yu-Jing Huang, Yajun Emily Zhu, Sarah Rybowski

Curr Med Res Opin· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age.
Lynn Borgatta, Kai J Buhling, Sarah Rybowski, Katrin Roth, Kimberly Rosen

Eur J Contracept Reprod Health Care· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
Dan Apter, Paula Briggs, Marjo Tuppurainen, Julia Grunert, Eeva Lukkari-Lax, Sarah Rybowski

Fertil Steril· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial.
Kristina Gemzell-Danielsson, Dan Apter, Brian Hauck, Thomas Schmelter, Sarah Rybowski

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial.
Anita Nelson, Dan Apter, Brian Hauck, Thomas Schmelter, Sarah Rybowski

Obstet Gynecol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Women's attitudes towards monthly bleeding: results of a global population-based survey.
Anne Szarewski, Ariane von Stenglin, Sarah Rybowski

Eur J Contracept Reprod Health Care· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in intrauterine technique training.
Anne Connolly, Sarah Rybowski

J Fam Plann Reprod Health Care· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuation rates and satisfaction with the Levonorgestrel Intrauterine System. Letter to the Editor in response to an article published in volume 31, by Dr. Ewies.
Sarah Rybowski, Pirjo Inki

Gynecol Endocrinol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis